Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Sep;27(9):908-917.
doi: 10.1016/j.jagp.2019.03.016. Epub 2019 Mar 27.

Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients

Lirong Wang  1 , Jian Ying  2 , Peihao Fan  1 , Elise A Weamer  3 , Mary Ann A DeMichele-Sweet  4 , Oscar L Lopez  5 , Julia K Kofler  6 , Robert A Sweet  7
Affiliations
Comparative Study

Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients

Lirong Wang et al. Am J Geriatr Psychiatry. 2019 Sep.

Abstract

Objective: To identify medications that may prevent psychosis in patients with Alzheimer disease (AD).

Methods: The authors compared the frequency of medication usage among patients with AD with or without psychosis symptoms (AD + P versus AD - P). The authors also conducted survival analysis on time to psychosis for patients with AD to identify drugs with beneficial effects. The authors further explored the potential molecular mechanisms of identified drugs by gene-signature analysis. Specifically, the gene expression profiles induced by the identified drug(s) were collected to derive a list of most perturbed genes. These genes were further analyzed by the associations of their genetic variations with AD or psychosis-related phenotypes.

Results: Vitamin D was used more often in AD - P patients than in AD + P patients. Vitamin D was also significantly associated with delayed time to psychosis. AD and/or psychosis-related genes were enriched in the list of genes most perturbed by vitamin D, specifically genes involved in the regulation of calcium signaling downstream of the vitamin D receptor.

Conclusion: Vitamin D was associated with delayed onset of psychotic symptoms in patients with AD. Its mechanisms of action provide a novel direction for development of drugs to prevent or treat psychosis in AD. In addition, genetic variations in vitamin D-regulated genes may provide a biomarker signature to identify a subpopulation of patients who can benefit from vitamin D treatment.

Keywords: Alzheimer disease; clinical data-mining; cognitive decline; psychosis symptoms; systems pharmacology; vitamin D.

PubMed Disclaimer

Comment in

References

    1. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7(3):263–9. doi: DOI 10.1016/j.jalz.2011.03.005. - DOI - PMC - PubMed
    1. Langa KM, Larson EB, Crimmins EM, Faul JD, Levine DA, Kabeto MU, Weir DR. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Internal Medicine 2017;177(1):51–8. - PMC - PubMed
    1. Liu H, Wang L, Su W, Xie X-Q. Advances in recent patent and clinical trial drug development for Alzheimer’s disease. Pharmaceutical patent analyst 2014;3(4):429–47. - PMC - PubMed
    1. Emanuel JE, Lopez OL, Houck PR, Becker JT, Weamer EA, DeMichele-Sweet MAA, Kuller L, Sweet RA. Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health study. The American Journal of Geriatric Psychiatry 2011;19(2):160–8. - PMC - PubMed
    1. Seltman HJ, Mitchell S, Sweet RA. A Bayesian model of psychosis symptom trajectory in Alzheimer’s disease. International journal of geriatric psychiatry 2016;31(2):204–10. - PMC - PubMed

Publication types